(Q80370987)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

title

[Severe cutaneous toxicity after Pemetrexed as second line treatment for a refractory non small cell lung cancer] (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

author name string

C Tummino

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

F Barlesi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

C Tchouhadjian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

A M Tasei

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

C Gaudy-Marqueste

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

M A Richard

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

P Astoul

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

publication date

1 May 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

Revue des Maladies Respiratoires

31 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

page(s)

635-638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

Randomized phase III trial of pemetrexed versus docetaxel in patients with non-small-cell lung cancer previously treated with chemotherapy

31 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Multitargeted antifolate LY231514 as first-line chemotherapy for patients with advanced non-small-cell lung cancer: A phase II study. National Cancer Institute of Canada Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Radiation recall dermatitis with pemetrexed

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Toxic Epidermal Necrolysis Associated with Gemcitabine Therapy in a Patient with Metastatic Transitional Cell Carcinoma of the Bladder

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Methotrexate-induced bullous acral erythema in a child

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Novel treatments for drug-induced toxic epidermal necrolysis (Lyell's syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Treatment of toxic epidermal necrolysis. Experience with 9 patients with consideration of intravenous immunoglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding

1 reference

https://api.crossref.org/works/10.1016%2FS0761-8425%2807%2991133-X

7 January 2021

10.1016/S0761-8425(07)91133-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17519817%20AND%20SRC:MED&resulttype=core&format=json

31 December 2019

1 reference